Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling

This study has been completed.
Eli Lilly and Company
University of Cincinnati
Information provided by (Responsible Party):
Lindner Center of HOPE Identifier:
First received: February 20, 2007
Last updated: December 12, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)